Safety and efficacy of tiotropium Respimat versus HandiHaler in patients naive to treatment with inhaled anticholinergics: a post hoc analysis of the TIOSPIR trial

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) who were naive to anticholinergics before the TIOtropium Safety and Performance In Respimat (TIOSPIR) trial may reflect patients seen in practice, in particular in primary care. In addition, investigating safety in these patients...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:NPJ Prim Care Respir Med
Hlavní autoři: Wise, Robert, Calverley, Peter MA, Dahl, Ronald, Dusser, Daniel, Metzdorf, Norbert, Müller, Achim, Fowler, Andy, Anzueto, Antonio
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4634206/
https://ncbi.nlm.nih.gov/pubmed/26540491
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npjpcrm.2015.67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky